Terazosin is a prescription medication used primarily to treat two conditions: benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate, and high blood pressure. It works by relaxing smooth muscle in the prostate and blood vessels, which improves urine flow in men with BPH and lowers blood pressure in people with hypertension.
How Terazosin Works
Terazosin belongs to a class of drugs called alpha-1 blockers. Throughout your body, tiny receptors on smooth muscle cells respond to adrenaline-like signals by tightening. Terazosin blocks those receptors, preventing the muscles from contracting. In the prostate and bladder neck, this relaxation opens up the urinary channel. In blood vessel walls, it widens the vessels and reduces blood pressure.
The drug reaches peak levels in the blood about one hour after you take it and has a half-life of roughly 12 hours, meaning its effects generally persist for a full 24-hour dosing cycle.
Enlarged Prostate (BPH)
BPH is the most common reason terazosin is prescribed. As the prostate grows with age, it squeezes the urethra and makes urination difficult. Symptoms include a weak stream, frequent urination (especially at night), difficulty starting, and the feeling that the bladder hasn’t fully emptied.
In a randomized, placebo-controlled trial of 285 men, all terazosin groups showed significantly greater improvement in symptom scores compared to placebo. The 10 mg group also had meaningfully better peak urinary flow rates. Most men need a dose of 10 mg once daily to see a clinical response, and it typically takes four to six weeks at that dose before you can judge whether the medication is working for you. Improvements in symptoms and flow rates didn’t plateau within the dose range studied, suggesting some men benefit from going higher, though doses above 20 mg daily aren’t well supported by data.
Terazosin doesn’t shrink the prostate. It simply relaxes the muscle around it, so symptoms return if you stop taking it.
High Blood Pressure
Terazosin also lowers blood pressure, though it’s rarely the first drug chosen for hypertension today. In men taking it for BPH, the addition of terazosin reduced systolic blood pressure by about 5 to 7 mmHg on average. For men who were hypertensive at the start of treatment, the drop was more pronounced: around 11 to 12 mmHg in systolic pressure regardless of whether they were already on other blood pressure medications. The effect was strongest in patients already taking a diuretic, where the average systolic drop reached 12.3 mmHg.
The usual maintenance dose for hypertension is 1 to 5 mg once daily, though some people need up to 20 mg. If the blood pressure effect wears off before the next dose, splitting it into twice-daily dosing is an option.
How Terazosin Compares to Tamsulosin
Tamsulosin (Flomax) is the other widely prescribed alpha blocker for BPH, and the two are often compared. In a head-to-head trial, tamsulosin improved symptom scores by 4.8 points versus 3.4 for terazosin over 25 days. Part of that early advantage comes from dosing logistics: tamsulosin starts at its full 0.4 mg dose with no titration, while terazosin must be slowly increased from 1 mg to 5 mg over about two weeks before reaching therapeutic levels.
Side effects also differ. Dizziness occurred in 12.1% of men taking terazosin compared to 5.5% on tamsulosin, and drowsiness was about three times more common with terazosin. Tamsulosin is more selective for the receptors in the prostate, so it has less effect on blood pressure. That selectivity makes tamsulosin a better fit for men with normal blood pressure, while terazosin can pull double duty for men who have both BPH and hypertension.
Starting the Medication Safely
Terazosin carries a well-known risk of a “first-dose effect,” a sharp drop in blood pressure that can cause lightheadedness or fainting. In clinical trials, about 12.5% of patients experienced a significant blood pressure drop within the first three hours of dosing, compared to 4% on placebo. Syncope (fainting) occurred in roughly 1% of patients across larger trials. In early studies that ramped up the dose too quickly, fainting and severe drops in blood pressure (as low as 50/0 mmHg) were observed.
For both BPH and hypertension, the starting dose is always 1 mg taken at bedtime. The bedtime timing is deliberate: if your blood pressure drops sharply, you’re already lying down. From there, the dose is gradually increased. This slow titration is the main safeguard against dangerous blood pressure drops. If you miss several doses and restart, you’ll generally need to begin the titration process again.
Interaction With Erectile Dysfunction Drugs
One of the more important interactions to know about involves PDE5 inhibitors, the class of drugs used for erectile dysfunction. Both terazosin and these medications lower blood pressure, and combining them can cause a dangerous drop. In a study comparing alpha blockers, 19 of 29 men taking terazosin experienced a standing systolic blood pressure below 85 mmHg or a drop greater than 30 mmHg when taking both drugs simultaneously. That arm of the study was terminated early because of safety concerns.
Timing matters significantly. Taking the two medications six hours apart rather than at the same time reduced the frequency of dangerous blood pressure drops. Current FDA guidance recommends that if you’re already stable on terazosin, an erectile dysfunction medication can be started at a low dose. If you’re starting terazosin while already on one of these drugs, you should begin terazosin at the lowest dose and increase cautiously.
Common Side Effects
Beyond the first-dose blood pressure drop, the most frequently reported side effects are dizziness, drowsiness, and fatigue. These tend to be most noticeable in the first few days and often improve as your body adjusts. Nasal congestion and blurred vision can also occur because the drug relaxes smooth muscle throughout the body, not just in the prostate and blood vessels.
One phenomenon worth knowing about is tolerance. Research published in The Journal of Clinical Investigation found that the body’s alpha-1 receptors can become less responsive to terazosin’s blocking effect over time, potentially reducing the drug’s effectiveness with chronic use. This is one reason some patients need dose increases as treatment continues.